Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vernakalant vs flecainide for pharmacological cardioversion of paroxysmal atrial fibrillation
2014-003641-95Phase 4Active
- Sponsor
- Nicasio Pérez Castellano
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vernakalant, flecainide in Atrial fibrillation (AFib), sponsored by Nicasio Pérez Castellano. Started Nov 2014; status: active.
02
Drugs
vernakalantflecainide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2014-003641-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003641-95.